ID

22459

Beschreibung

Study part: Investigational Product Discontinuation.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Stichworte

  1. 05.06.17 05.06.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

5. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Investigational Product Discontinuation Mepolizumab HES NCT00086658

Investigational Product Discontinuation

INVESTIGATIONAL PRODUCT DISCONTINUATION
Beschreibung

INVESTIGATIONAL PRODUCT DISCONTINUATION

Alias
UMLS CUI-1
C0013230
UMLS CUI-2
C0457454
Subject ID
Beschreibung

Subject ID

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Was the investigational product stopped permanently before the end of the scheduled treatment period?
Beschreibung

Investigational Product Discontinuation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0457454
The primary reason the investigational product was stopped:
Beschreibung

Reason Investigational Product Discontinuation

Datentyp

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0457454
If other, please specify
Beschreibung

Other

Datentyp

text

Alias
UMLS CUI [1]
C0205394

Ähnliche Modelle

Investigational Product Discontinuation

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
INVESTIGATIONAL PRODUCT DISCONTINUATION
C0013230 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Investigational Product Discontinuation
Item
Was the investigational product stopped permanently before the end of the scheduled treatment period?
boolean
C0013230 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
Item
The primary reason the investigational product was stopped:
text
C0392360 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Code List
The primary reason the investigational product was stopped:
CL Item
Lost to follow-up (Lost to follow-up)
C1302313 (UMLS CUI-1)
CL Item
Protocol violation (Protocol violation)
C1709750 (UMLS CUI-1)
CL Item
Subject decided to withdraw from the study (Subject decided to withdraw from the study)
C2348571 (UMLS CUI-1)
CL Item
Lack of efficacy (Lack of efficacy)
C0235828 (UMLS CUI-1)
CL Item
Sponsor terminated study (Sponsor terminated study)
C1710224 (UMLS CUI-1)
CL Item
Disease progression (Disease progression)
C0242656 (UMLS CUI-1)
CL Item
Other, specify (Other, specify)
C0205394 (UMLS CUI-1)
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate))
C0877248 (UMLS CUI-1)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video